AXT, Inc. Announces First Quarter 2026 Financial Results
Management Qualitative Comments
“This is an incredibly exciting time for AXT,” said
First Quarter 2026 Results
-
Revenue for the first quarter of 2026 was
$26.9 million , compared with$23.0 million for the fourth quarter of 2025 and$19.4 million for the first quarter of 2025.
- GAAP gross margin was 29.6 percent of revenue for the first quarter of 2026, compared with 20.9 percent of revenue for the fourth quarter of 2025 and (6.4) percent for the first quarter of 2025.
- Non-GAAP gross margin, after excluding charges for stock-based compensation, was 29.9 percent of revenue for the first quarter of 2026, compared with 21.5 percent of revenue for the fourth quarter of 2025 and (6.1) percent for the first quarter of 2025.
-
GAAP net loss, after minority interests, for the first quarter of 2026 was a net loss of
$1.6 million , or$0.03 per share, compared with a net loss of$3.5 million , or$0.08 per share, for the fourth quarter of 2025 and a net loss of$8.8 million , or$0.20 per share, for the first quarter of 2025.
-
Non-GAAP net loss for the first quarter of 2026 was a net loss of
$0.6 million , or$0.01 per share, compared with a net loss of$2.3 million , or$0.05 per share, for the fourth quarter of 2025 and a net loss of$8.2 million , or$0.19 per share, for the first quarter of 2025.
STAR Market Listing Update
On
Conference Call
The company will host a conference call to discuss these results today at
About
AXT is a material science company that develops and manufactures high-performance compound and single element semiconductor substrate wafers comprising indium phosphide (InP), gallium arsenide (GaAs) and germanium (Ge). The company’s substrate wafers are used when a typical silicon substrate wafer cannot meet the performance requirements of a semiconductor or optoelectronic device. End markets include 5G infrastructure, data center connectivity (silicon photonics), passive optical networks, LED lighting, lasers, sensors, power amplifiers for wireless devices and satellite solar cells. AXT’s worldwide headquarters are in
Safe Harbor Statement
This press release contains certain statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, for example, our plans and ability to step up by adding manufacturing capacity and to enable our industry to meet future demands and needs for our indium phosphide wafer substrates. Statements relating to our expectations regarding the receipt of export permits for our indium phosphide substrates, results of operations, market and customer demand for our products, our ability to expand our markets or increase sales, emerging applications using chips or devices fabricated on our substrates, including the use of indium phosphide wafer substrates in artificial intelligence (“AI”) applications, product yields and gross margins, expense levels, our investments in capital projects, ramping production at our sites, our ability to utilize or increase our manufacturing capacity, and our belief that we have adequate cash and investments to meet our needs are also forward-looking statements. Additionally, statements regarding completing steps in connection with the proposed listing of shares of Tongmei on the Shanghai Stock Exchange’s Sci-Tech innovAtion boaRd (the “STAR Market”), being accepted to list shares of Tongmei on the STAR Market, the timing and completion of such listing of shares of Tongmei on the STAR Market are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “potentially,” “likely,” and similar expressions and variations thereof are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These statements appear in this press release and elsewhere, include statements regarding the intent, belief or current expectations of our management that are subject to known and unknown risks, uncertainties and assumptions which could cause actual results to differ materially from those expressed or implied in the forward-looking statement. These risks, uncertainties and assumptions include, but are not limited to, the receipt of export permits for our indium phosphide substrates, the withdrawal, cancellations or requests for redemptions by private equity funds in
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share data) |
||||||||
|
|
|
Three Months Ended |
||||||
|
|
|
|
||||||
|
|
|
2026 |
|
2025 |
||||
|
|
|
|
|
|
|
|
||
|
Revenue |
|
$ |
26,924 |
|
|
$ |
19,356 |
|
|
Cost of revenue |
|
|
18,946 |
|
|
|
20,597 |
|
|
Gross profit (loss) |
|
|
7,978 |
|
|
|
(1,241 |
) |
|
Operating expenses: |
|
|
|
|
|
|
||
|
Selling, general and administrative |
|
|
6,551 |
|
|
|
5,916 |
|
|
Research and development |
|
|
3,012 |
|
|
|
3,118 |
|
|
Total operating expenses |
|
|
9,563 |
|
|
|
9,034 |
|
|
Loss from operations |
|
|
(1,585 |
) |
|
|
(10,275 |
) |
|
Interest income (expense), net |
|
|
101 |
|
|
|
(269 |
) |
|
Equity in income of unconsolidated joint ventures |
|
|
353 |
|
|
|
248 |
|
|
Other income, net |
|
|
76 |
|
|
|
354 |
|
|
Loss before provision for income taxes |
|
|
(1,055 |
) |
|
|
(9,942 |
) |
|
Provision for income taxes |
|
|
430 |
|
|
|
74 |
|
|
Net loss |
|
|
(1,485 |
) |
|
|
(10,016 |
) |
|
Less: Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests |
|
|
(135 |
) |
|
|
1,218 |
|
|
Net loss attributable to |
|
$ |
(1,620 |
) |
|
$ |
(8,798 |
) |
|
Net loss attributable to |
|
|
|
|
|
|
||
|
Basic |
|
$ |
(0.03 |
) |
|
$ |
(0.20 |
) |
|
Diluted |
|
$ |
(0.03 |
) |
|
$ |
(0.20 |
) |
|
Weighted-average number of common shares outstanding: |
|
|
|
|
|
|
||
|
Basic |
|
|
53,319 |
|
|
|
43,554 |
|
|
Diluted |
|
|
53,319 |
|
|
|
43,554 |
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands) |
||||||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
2026 |
|
2025 |
||||
|
|
|
|
|
|
|
|
||
|
ASSETS |
|
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
41,769 |
|
|
$ |
120,266 |
|
|
Restricted cash |
|
|
16,100 |
|
|
|
8,100 |
|
|
Short-term investments |
|
|
65,375 |
|
|
|
— |
|
|
Accounts receivable, net |
|
|
32,016 |
|
|
|
26,849 |
|
|
Inventories |
|
|
90,168 |
|
|
|
81,651 |
|
|
Prepaid expenses and other current assets |
|
|
8,347 |
|
|
|
9,690 |
|
|
Total current assets |
|
|
253,775 |
|
|
|
246,556 |
|
|
Property, plant and equipment, net |
|
|
164,622 |
|
|
|
161,860 |
|
|
Operating lease right-of-use assets |
|
|
1,854 |
|
|
|
1,982 |
|
|
Other assets |
|
|
24,347 |
|
|
|
23,353 |
|
|
Total assets |
|
$ |
444,598 |
|
|
$ |
433,751 |
|
|
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
|
||
|
Accounts payable |
|
$ |
16,141 |
|
|
$ |
12,947 |
|
|
Accrued liabilities |
|
|
12,864 |
|
|
|
14,798 |
|
|
Short-term loans |
|
|
68,871 |
|
|
|
62,796 |
|
|
Total current liabilities |
|
|
97,876 |
|
|
|
90,541 |
|
|
Noncurrent operating lease liabilities |
|
|
1,309 |
|
|
|
1,441 |
|
|
Other long-term liabilities |
|
|
8,447 |
|
|
|
7,138 |
|
|
Total liabilities |
|
|
107,632 |
|
|
|
99,120 |
|
|
|
|
|
|
|
|
|
||
|
Redeemable noncontrolling interests |
|
|
38,516 |
|
|
|
38,056 |
|
|
|
|
|
|
|
|
|
||
|
Stockholders’ equity: |
|
|
|
|
|
|
||
|
Preferred stock |
|
|
3,532 |
|
|
|
3,532 |
|
|
Common stock |
|
|
56 |
|
|
|
55 |
|
|
Additional paid-in capital |
|
|
342,434 |
|
|
|
339,922 |
|
|
Accumulated deficit |
|
|
(66,544 |
) |
|
|
(64,924 |
) |
|
Accumulated other comprehensive loss |
|
|
(4,604 |
) |
|
|
(5,295 |
) |
|
|
|
|
274,874 |
|
|
|
273,290 |
|
|
Noncontrolling interests |
|
|
23,576 |
|
|
|
23,285 |
|
|
Total stockholders’ equity |
|
|
298,450 |
|
|
|
296,575 |
|
|
Total liabilities, redeemable noncontrolling interests and stockholders’ equity |
|
$ |
444,598 |
|
|
$ |
433,751 |
|
|
Reconciliation of Statements of Operations Under GAAP and Non-GAAP (Unaudited, in thousands) |
||||||||
|
|
|
|
||||||
|
|
|
Three Months Ended |
||||||
|
|
|
|
||||||
|
|
|
2026 |
|
2025 |
||||
|
GAAP gross profit (loss) |
|
$ |
7,978 |
|
|
$ |
(1,241 |
) |
|
Stock-based compensation expense |
|
|
65 |
|
|
|
63 |
|
|
Non-GAAP gross profit (loss) |
|
$ |
8,043 |
|
|
$ |
(1,178 |
) |
|
|
|
|
|
|
|
|
||
|
GAAP operating expenses |
|
$ |
9,563 |
|
|
$ |
9,034 |
|
|
Stock-based compensation expense |
|
|
970 |
|
|
|
583 |
|
|
Non-GAAP operating expenses |
|
$ |
8,593 |
|
|
$ |
8,451 |
|
|
|
|
|
|
|
|
|
||
|
GAAP loss from operations |
|
$ |
(1,585 |
) |
|
$ |
(10,275 |
) |
|
Stock-based compensation expense |
|
|
1,035 |
|
|
|
646 |
|
|
Non-GAAP loss from operations |
|
$ |
(550 |
) |
|
$ |
(9,629 |
) |
|
|
|
|
|
|
|
|
||
|
GAAP net loss |
|
$ |
(1,620 |
) |
|
$ |
(8,798 |
) |
|
Stock-based compensation expense |
|
|
1,035 |
|
|
|
646 |
|
|
Non-GAAP net loss |
|
$ |
(585 |
) |
|
$ |
(8,152 |
) |
|
|
|
|
|
|
|
|
||
|
GAAP net loss per diluted share |
|
$ |
(0.03 |
) |
|
$ |
(0.20 |
) |
|
Stock-based compensation expense per diluted share |
|
$ |
0.02 |
|
|
$ |
0.01 |
|
|
Non-GAAP net loss per diluted share |
|
$ |
(0.01 |
) |
|
$ |
(0.19 |
) |
|
|
|
|
|
|
|
|
||
|
Shares used to compute diluted net income per share |
|
|
53,319 |
|
|
|
43,554 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260430987825/en/
Chief Financial Officer
(510) 438-4700
(650) 312-9060
Source: